Christoph Rentsch
Director/Miembro de la Junta en Targimmune Therapeutics AG .
Cargos activos de Christoph Rentsch
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Director/Miembro de la Junta | - | - |
Historial de carrera de Christoph Rentsch
Antiguos cargos conocidos de Christoph Rentsch.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SANTHERA PHARMACEUTICALS HOLDING AG | Director Financiero/CFO | 01/07/2015 | 31/12/2019 |
Public Communications Contact | 01/07/2015 | 31/12/2019 | |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Director/Miembro de la Junta | - | - |
Credit Suisse AG
Credit Suisse AG Investment ManagersFinance Credit Suisse AG is an investment management firm headquartered in Zurich, Switzerland. The firm was founded in 1856 and was acquired by UBS Group AG (SWX: UBSG) from Credit Suisse Group AG in 2023. Credit Suisse manages global and regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals worldwide. They also offer private banking and wealth management, investment banking, and corporate and business support services. | Corporate Officer/Principal | - | - |
Alusuisse-Lonza America, Inc. | Director Financiero/CFO | - | - |
Alusuisse Group Ltd. | Treasurer | - | - |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - | - |
Caperis Partners AG | Corporate Officer/Principal | 01/01/2003 | - |
SPEXIS AG | Director Financiero/CFO | - | - |
Formación de Christoph Rentsch.
University of Applied Sciences Basel | Undergraduate Degree |
Estadísticas
Internacional
Suiza | 10 |
Estados Unidos | 2 |
Operativa
Director of Finance/CFO | 3 |
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Sectorial
Health Technology | 5 |
Finance | 3 |
Distribution Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
SPEXIS AG | Health Technology |
SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
Empresas privadas | 7 |
---|---|
Caperis Partners AG | |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Alusuisse Group Ltd. | Distribution Services |
Alusuisse-Lonza America, Inc. | |
Credit Suisse AG
Credit Suisse AG Investment ManagersFinance Credit Suisse AG is an investment management firm headquartered in Zurich, Switzerland. The firm was founded in 1856 and was acquired by UBS Group AG (SWX: UBSG) from Credit Suisse Group AG in 2023. Credit Suisse manages global and regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals worldwide. They also offer private banking and wealth management, investment banking, and corporate and business support services. | Finance |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Christoph Rentsch
- Experiencia